Phitech Logo   PHINANCE TECHNOLOGIES HUMANITY PROJECTS PROJECTS PROJECTS FUNDING RESOURCES ABOUT FAQ
Go to top Clinical trials and efficacy Severe or fatal adverse Events Non-fatal adverse events Other references of interest Contact Us

References to academic literature related to Covid-19 vaccines



Below we provide some academic references that we think are of particular interest for understanding the damage related to the Covid-19 vaccines. The list is not exaustive as there are now numerous papers that now show the detrimental impacts of the vaccines. We focus here on papers that are directly related to our work in mapping out the human damage that is likely caused by the novel innoculations. Some of these papers are still in pre-print format as they are awaiting peer review.

It should also be noted that to date, there has been an extremelly negative bias for journals publishing papers that questioned the safety or efficacy of the Covid-19 vaccines. However, from late 2023, academic literature with independent investigation of vaccine adverse effects has been surfacing in different countries.


Last update date: December - 2023



Clinical trials and vaccine efficacy

  • Polack et al., “Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine”, NEJM (December 2020). Link to paper.
    The authors of Polack et al. consisted of the site administrators of the 153 clinical trial sites in over 6 different countries. Fernando P. Polack, MD, was Principal Investigator and site administrator of the trial site in Argentina and Stephen J. Thomas, MD, the lead co-author, was the chief Principal Investigator of Clinical Trial C4591001. Thus, the authors of these publications were obliged to be and should have been intimately familiar with the trial findings.

  • Thomas et al., "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine through 6 months", NEJM (September 2021). Link: Link to paper
    Published by the same group of site administrators for the Pfizer clinical trial (as above).

  • C. Michels et al, "Forensic analysis of the 38 subject deaths in the 6-Month Interim Report of the Pfizer/BioNTech BNT162b2 mRNA Vaccine Clinical Trial". International Journal of Vaccine Theory, Practice, and Research , 3(1), 973-1008, (October 2023). Link to paper.
    Provides a forensic analysis of the BNT162b2 mRNA clinical trials and the timeline of released documents and up to the 6 month mark (after the unblinding), in March 2021.

  • J. Fraiman et al, "Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults". Vaccine, Vol. 40, Issue 40, pp 5798-5805 (September 2023). Link to paper.
    Provides an independent investigation the Serious Adverse Events (SAE) in the Pfizer and Moderna clinical trials prior to the unblinding of the participants.

  • Shrestha Nadin K. et al, "Risk of Coronavirus Disease 2019 (COVID-19) among Those Up-todate and Not Up-toDate on COVID-19 Vaccination". PLoS One. 2023 Nov 8;18(11):e0293449 Link to paper.
    This paper, "Clevend Clinic study", is one of the main early academic publications showing worse outcomes in acquiring Covid-19 in vaccinated individuals comprared to unvaccinated ones. The paper questions the efficacy of the Covid-19 vaccines. The first paper versions was very controversial as it questioned the vaccine safe-and-effective narrative. Consequently it was only published in a peer-review version in November of 2023.

  • Shrestha Nadin K. et al, "Effectiveness of mRNA COVID-19 Vaccines among Employees in an American Healthcare System". (August 2021) Pre-Print paper Link to paper.
    This paper is the original "Clevend Clinic study" pre-print version, published in June of 2021.


Severe or fatal adverse events


  • Salsone, M. et al, "NEURO-COVAX: An Italian Population-Based Study of Neurological Complications after COVID-19 Vaccinations". Vaccines, 11(10), 1621 (October 2023). Link to paper.
    Population-based survey of neurological complications post- Covid-19 vaccination in Italy.

  • Husby A. et al, "SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study". BMJ 2021; 375 (November 2021). Link to paper.
    Population-based passive survey of myocarditis damage post- Covid-19 vaccination in Denmark.

  • Buergin N. et al, "Sex-specific differences in myocardial injury incidence after COVID-19 mRNA-1273 booster vaccination". European Journal of Heart Failure, Vol 25(10), pp. 1871-1881 2021, (October 2023). Link to paper.
    This paper provides an estimate of the incidence rate of myocardial damage in vaccinated individuals, for Switzerland. It is of particular importance as it performes an active survey of post-vaccination heart damage, as compared to prior studies that are passive surveys.

  • Cho J. Y. et al, "Covid-19 vaccination-related myocarditis: a Korean nationwide study". European Heart Journal, Vol 44(24), pp. 2234-2243 2021;(June 2023). Link to paper.
    Population-based passive survey of myocarditis damage post- Covid-19 vaccination in South Korea.

  • Watanabe S. et al, "SARS-CoV-2 vaccine and increased myocarditis mortality risk: A population based comparative study in Japan". Pre-print paper. Not peer reviewed. (December 2022). Link to paper.
    Population-based passive survey of myocarditis damage post- Covid-19 vaccination in Japan.


Non-fatal adverse events

These research papers are of particular relevance as they investigate non-fatal adverse events related to the Covid-19 vaccinations. Until now, most of the litearture and concerns amongst scientists who are investigating post- Covid-19 vaccinations effects are focused mainly serious AEs such as cardiovascular, malignant neoplasms and neurological problems that can give rise to fatal conditions. However, the impact on individuals' health from adverse effects from the Covid-19 vaccinations are not limited to death, but also manifest as disabilities and milder injuries.

  • Eun Mi Chun et. al., "The spectrum of non-fatal immune-related adverse events following COVID-19 vaccination: The population-based cohort study in Seoul, South Korea". (11/2023). Pre-Print paper. Not Peer reviewed. Link to paper.
    Provides a population-based analysis of immune-related adverse events associated with the Covid-19 vaccinations in South Korea.

  • Eun Mi Chun et. al., "Hematologic abnormalities after COVID-19 vaccination: A large Korean population-based cohort study". (11/2023). Pre-Print paper. Not Peer reviewed. Link: Link to paper
    Investigates haematologic abnortmalities following Covid-19 vaccinations on a population-based cohort in South Korea.

  • Eun Mi Chun et. al., "Correlation between COVID-19 vaccination and inflammatory musculoskeletal disorders". (11/2023). Pre-Print paper. Not Peer reviewed. Link to paper.
    Population-based study from South Korea that investigates the relationship between inflammatory musculoskeletal disorders and the Covid-19 vaccinations.



Other papers of interest

These research papers are of relevance as they provide and understanding of the mechanisms behind either the Covid-19 disease or the Covid-19 vaccine damage.

  • O'Brian, Brittany C. V. et al., “SARS-CoV-2 spike ectodomain targets α7 nicotinic acetylcholine receptors”, Journal of Biological Chemistry, Vol. 299, No 5, pp. 1-15, (April 2023). Link to paper.
    Shows that the spike protein contains a neurotoxic region that is similar to the rabies virus, HIV glycoproteins as well as snake neurotoxins, which interact with nicotinic acetylcholine receptors. The paper provides a new aspect of the SARS-CoV-2 disease, its pathogenesis and how it interact with human cells.

  • Tizabi Y. et al., "Nicotine and the nicotinic cholinergic system in COVID-19", Federation of European Biochemical Societies Journal, Vol 287, pp. 3656-3663 (August 2020). Link: Link to paper
    The authors show, in 2020, the potential therapeutic role associated with nicotine for the treatment of Covid-19.